Amarin | AMRN - Ebitda

Биржевая цена
14.49
Изменение за день
-0.51 -3.40%
Ежемесячно
-7.29%
Ежегодный
58.50%
Q1 прогноз
14.88




Ebitda Изменить Дата
AbbVie USD 3.52B 828M 2025-09
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Amarin USD 12.54M 28.57M 2025-06
AstraZeneca USD 5.23B 272M 2025-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
DBV Technologies USD -33.48M 5.55M 2025-09
Esperion Therapeutics USD -9.93M 24.99M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 4.77B 1.11B 2025-12